Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
8.63
+0.02 (0.23%)
Jun 3, 2026, 9:30 AM EDT - Market open
Decoy Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
AI-designed multi-antivirals are advancing toward clinical trials, targeting large unmet needs in respiratory infections with rapid, cost-effective development and broad-spectrum efficacy. Strategic partnerships and non-dilutive funding support growth, with significant milestones expected in the next 12–24 months.